Competencies by care stage
Preparation
Building the therapeutic alliance, setting expectations, and readying the participant for the dosing experience.
272 competencies mapped to this stage.
Looking for something specific? Ask Blossom
Informed consent, decisional capacity, autonomy, and withdrawal rights
Teaches how to obtain and maintain valid informed consent through clear disclosure, comprehension checks, capacity support, voluntariness, non-coercion, and respect for refusal or withdrawal. The competency also covers consent for screening procedures, recordings, collateral contact, rescue interventions, and documentation of the consent process.
4 roles · 59 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreConfidentiality, privacy, and research data protection
Teaches protection of participant identity, sensitive clinical or occupational information, recordings, and research data. The competency covers coded identifiers, restricted access, secure handling, confidentiality safeguards, and privacy-preserving documentation.
5 roles · 53 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreScreening, eligibility, and readiness assessment
Teaches how to assess clinical suitability before psychedelic or ketamine treatment, including medical and psychiatric screening, readiness evaluation, contraindication review, inclusion/exclusion criteria, and ongoing eligibility re-checks before dosing.
8 roles · 52 guidelines · 15 courses · 12 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreAcute psychological response and emergency management during dosing
Cluster covering 35 related competencies for monitoring acute psychological effects, recognising and managing distress, crisis containment, emergency escalation, and rescue-medication coordination during psychedelic dosing sessions.
6 roles · 51 guidelines · 2 courses · 2 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreAdverse event identification, documentation, and reporting
Teaches how to detect, elicit, document, and report adverse events and serious adverse events across the participant journey. The focus is accurate source documentation, regulatory reporting discipline, follow-up, and preservation of participant safety and trial integrity.
4 roles · 46 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 morePreparation and integration support
Cluster covering 31 related competencies including: Integration support, Integration therapy, Integration coaching.
7 roles · 43 guidelines · 18 courses · 14 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreSuicide and serious psychiatric risk assessment
Teaches structured assessment of suicidal ideation, intent, psychiatric deterioration, and related high-risk presentations. Learners are trained to use appropriate tools, safety planning, emergency contacts, clinician access, and escalation pathways when risk is identified.
6 roles · 41 guidelines · 1 courses · 1 providers
5-MeO-DMTDMT / AyahuascaKetamine+3 moreManual fidelity, protocol adherence, and deviation management
Teaches faithful delivery of manualized treatment and protocol-defined procedures while documenting and managing unavoidable deviations. The competency protects participant welfare, treatment consistency, data integrity, and sponsor oversight.
5 roles · 39 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+4 morePost-dose follow-up, safety monitoring, and retention support
Teaches ongoing participant contact after dosing to support stability, detect delayed adverse effects, maintain therapeutic containment, and sustain adherence to follow-up visits and outcome assessments.
5 roles · 37 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreDischarge readiness, escort safety, and post-session supervision
Teaches how to determine when a participant is safe to leave after dosing and how to arrange appropriate supervision afterward. The competency covers psychological and physical stability, escort/support-person coordination, discharge restrictions, overnight or post-session support, and follow-up contact when needed.
4 roles · 30 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+3 moreEmergency recognition, escalation, and disposition planning
Teaches recognition of medical or psychiatric emergencies and the steps required to escalate care safely. The competency includes de-escalation, clinical consultation, 911 or emergency department transfer, serious-event escalation, and referral to appropriate higher-level care.
7 roles · 29 guidelines · 3 courses · 3 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreBlinding, allocation concealment, and unblinding control
Teaches how to preserve blinded trial conduct across participant interactions, outcome collection, staff roles, and session procedures. The competency includes preventing accidental unblinding, minimizing bias, and using emergency unblinding only when clinically necessary.
6 roles · 29 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+4 moreMedication, substance-use, washout, and taper management
Teaches review and management of concomitant medications, restricted therapies, prohibited substances, washout periods, tapering requirements, and abstinence expectations. The competency includes participant counseling, medication reconciliation, sponsor notification, and team coordination when restrictions affect safety or interpretability.
5 roles · 29 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+3 moreStudy documentation, data integrity, and regulatory recordkeeping
Teaches accurate study documentation, source-record quality, secure data capture, Good Clinical Practice recordkeeping, IRB and sponsor documentation requirements, monitoring readiness, audit support, accountability, and retention obligations.
3 roles · 27 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreManualized psychedelic psychotherapy delivery
Teaches delivery of psychedelic-assisted psychotherapy according to an approved study manual across preparation, dosing, integration, and follow-up. The competency balances standardized structure with non-directive support for the participant’s therapeutic process.
4 roles · 25 guidelines · 3 courses · 2 providers
KetamineLSDMDMA+1 moreTherapeutic boundaries, professional conduct, and consent for touch
Teaches how to maintain clear relational and physical boundaries in emotionally vulnerable treatment settings. This includes professional conduct, rapport without overreach, explicit consent for touch, the right to revoke consent, and strict prohibition of sexual or erotic contact.
7 roles · 24 guidelines · 4 courses · 3 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreCo-therapist and multidisciplinary team coordination
Teaches coordinated practice across co-therapists, physicians, psychiatrists, study coordinators, principal investigators, and other care-team members. The focus is shared responsibility, clear communication, role clarity, and coordinated observation of participant status.
4 roles · 24 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreStudy record and trial registration literacy
Teaches how to understand ClinicalTrials.gov records and related study information, including glossary terms, registration fields, protocol descriptors, and results-reporting elements used to interpret clinical research records.
3 roles · 24 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+3 morePhysical safety monitoring
Cluster covering 3 related competencies including: Physical safety monitoring, Safety monitoring during dosing sessions, Medical safety monitoring during psilocybin administration.
5 roles · 19 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+2 moreAcute psychiatric and behavioral risk monitoring
Teaches continuous monitoring for distress, confusion, psychotic symptoms, suicidality, agitation, and other acute behavioral risks during and after dosing. The focus is early recognition, documentation, and escalation to clinical support when risk emerges.
5 roles · 17 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+3 morePreparation support
Cluster covering 11 related competencies including: Preparation support, Psilocybin preparation, Therapeutic preparation.
3 roles · 16 guidelines · 6 courses · 5 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreEthical conduct in human-subject research
Able to practice ethically in a clinical trial environment involving a Schedule-sensitive psychoactive intervention. This includes protecting participants, adhering to protocol, and supporting valid informed participation.
3 roles · 16 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineLSD+3 moreSupportive nondirective therapeutic stance
Cluster covering 6 related competencies including: Therapeutic support during dosing, Nondirective dosing-session presence, Supportive dosing-session facilitation.
2 roles · 16 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaMDMA+1 moreTherapeutic alliance building
Cluster covering 2 related competencies including: Therapeutic alliance building, Therapeutic alliance and rapport building.
2 roles · 15 guidelines · 1 courses · 1 providers
5-MeO-DMTDMT / AyahuascaMDMA+1 moreGood Clinical Practice and protocol procedure compliance
Teaches adherence to Good Clinical Practice, assigned study roles, protocol procedures, delegation boundaries, and applicable research regulations. The competency supports consistent execution of approved procedures across sites and participants.
4 roles · 15 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+2 morePsilocybin session facilitation
Cluster covering 9 related competencies including: Psilocybin facilitation, Psilocybin session support, Psilocybin facilitation basics.
6 roles · 14 guidelines · 6 courses · 5 providers
LSDPsilocybinAdverse effects and side-effect management
Teaches recognition and management of expected and unexpected side effects during psychedelic or ketamine treatment. The competency emphasizes active observation, supportive response, and clinical escalation when symptoms exceed routine tolerability.
6 roles · 14 guidelines · 1 courses · 1 providers
DMT / AyahuascaIbogaineKetamine+3 morePsychedelic-assisted psychotherapy preparation and integration
Teaches structured pre-dose preparation and post-dose integration as the therapeutic frame for psychedelic-assisted psychotherapy. The therapist supports rapport, intention clarification, meaning-making, emotional processing, and consolidation of insights after dosing.
6 roles · 13 guidelines · 2 courses · 2 providers
5-MeO-DMTDMT / AyahuascaKetamine+3 moreHallucinogen pharmacology and effects
Cluster covering 7 related competencies including: Physiologic safety awareness, Hallucinogen pharmacology and effects, Hallucinogen-assisted therapy knowledge.
4 roles · 13 guidelines · 0 courses · 0 providers
LSDPsilocybinKetamine psychotherapy delivery
Cluster covering 12 related competencies including: KAP psychotherapy delivery, Ketamine and KAP knowledge, Ketamine integration planning.
6 roles · 12 guidelines · 7 courses · 5 providers
KetamineDissociation and acute neuropsychiatric effect monitoring
Teaches recognition and documentation of dissociation, psychosis-like symptoms, mania, and other acute neuropsychiatric effects that can occur after ketamine, psychedelic dosing, or related interventions. The focus is monitoring, reporting, and escalation when symptoms become clinically significant.
5 roles · 12 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineKetamine+1 moreSpecial-interest adverse event vigilance
The protocol requires active monitoring for psychedelic-specific adverse events such as hallucinations, psychotic symptoms, dissociation, mood alteration, and cognitive disturbance. These require immediate notification and follow-up.
3 roles · 11 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+3 moreMindfulness, intention-setting, set and setting, and somatic presence
Teaches practices that support preparation and therapeutic presence, including mindfulness, intention-setting, body-aware attention, environmental preparation, mindset awareness, and regulation through somatic presence.
6 roles · 9 guidelines · 7 courses · 6 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreTrauma-informed therapeutic presence and somatic support
Teaches a trauma-informed stance during psychedelic work, including calm presence, non-verbal reassurance, body-aware support, somatic orientation, and containment through difficult experiences while maintaining safety and boundaries.
2 roles · 9 guidelines · 2 courses · 2 providers
KetamineMDMAPsilocybinEnsure confidentiality and session containment
Maintain a contained therapeutic environment that protects the patient’s privacy and minimizes unwanted exposure. The session structure emphasizes confidentiality and controlled access to stimulation and outside contact.
2 roles · 9 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetamineMDMA+1 moreGrounding and regulation techniques
Therapists must be able to teach and coach grounding practices that help participants regulate during preparation and dosing. These methods are used before medication and during distress.
2 roles · 9 guidelines · 0 courses · 0 providers
MDMAPsilocybinOutcome Measure and Assessment Literacy
Teaches clinicians and research staff to understand the purpose, limits, scoring, interpretation, and clinical meaning of psychological measures and study instruments used to evaluate symptoms, functioning, safety, and treatment outcomes.
3 roles · 9 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+2 moreClient preparation and therapeutic set/setting
Cluster covering 2 related competencies including: Preparation of set and setting, Client preparation and therapeutic set/setting.
3 roles · 8 guidelines · 2 courses · 2 providers
DMT / AyahuascaKetamineLSD+2 moreContinuation, discontinuation, and risk-benefit judgment
Teaches how clinicians determine whether a participant should proceed, pause, discontinue dosing, or terminate study participation. The competency centers on safety-driven clinical judgment, risk-benefit assessment, and early termination when continuation is no longer appropriate.
5 roles · 8 guidelines · 0 courses · 0 providers
KetamineMDMAPsilocybinParticipant safety restriction counseling
Teaches how to instruct participants on post-dose and study-period restrictions that reduce risk from impaired judgment, unsafe activity, prohibited substances, or behaviors that could confound study outcomes.
3 roles · 8 guidelines · 0 courses · 0 providers
5-MeO-DMTIbogaineKetamine+2 morePhysiologic monitoring during ketamine administration
Cluster covering 2 related competencies including: Safety monitoring during ketamine dosing, Physiologic monitoring during ketamine administration.
4 roles · 8 guidelines · 0 courses · 0 providers
KetaminePsychedelic-assisted therapy facilitation
Cluster covering 2 related competencies including: Psychedelic-assisted therapy facilitation, Group facilitation in a psychedelic setting.
3 roles · 8 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetamineLSD+2 morePsychological support during altered states
Provides supportive therapeutic presence while the patient is under the influence of ketamine. Uses calming, noncoercive guidance to help the patient navigate dissociation and emotional material.
3 roles · 8 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+3 moreTraining and competency maintenance
Therapists and study personnel are expected to receive structured training and ongoing supervision. Competence includes both protocol adherence and the ability to work safely and consistently across sites.
3 roles · 8 guidelines · 0 courses · 0 providers
MDMAPsilocybinCultural humility, Indigenous respect, and equity-oriented care
Teaches culturally responsive psychedelic care, including humility, anti-bias practice, Indigenous and traditional-use awareness, cultural appropriation concerns, diversity and inclusion, and respectful work with marginalized communities.
6 roles · 7 guidelines · 11 courses · 10 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreTransference, countertransference, and therapist self-awareness
Teaches recognition and management of relational dynamics that can intensify in psychedelic-assisted therapy. Learners develop self-awareness around countertransference, projection, attachment, dependency, and other therapeutic-process risks.
3 roles · 7 guidelines · 1 courses · 1 providers
5-MeO-DMTKetamineMDMA+1 moreClinical interviewing and history-taking
Therapists and study clinicians perform detailed biopsychosocial interviewing during preparation and screening. This supports treatment planning, risk assessment, and therapeutic understanding.
2 roles · 7 guidelines · 0 courses · 0 providers
KetamineMDMAPsilocybinClinical Interviewing and PTSD Assessment
Teaches structured clinical interviewing and assessment administration for PTSD and related symptom domains, including symptom severity, functional impairment, risk factors, and appropriate use of standardized assessment tools.
2 roles · 7 guidelines · 0 courses · 0 providers
KetamineMDMAMedical escalation and rescue medication coordination
Cluster covering 2 related competencies including: Medical escalation and rescue medication use, Medical escalation and rescue medication coordination.
4 roles · 7 guidelines · 0 courses · 0 providers
5-MeO-DMTPsilocybinParticipant-centered discharge planning and aftercare
Support decision-making about ongoing treatment after trial completion, particularly for participants who received escitalopram. The clinician helps participants consider whether to continue, taper, or return to usual care.
3 roles · 7 guidelines · 0 courses · 0 providers
IbogaineKetamineMDMA+1 moreSafe Therapeutic Container Creation
Teaches providers to create and maintain a psychologically and physically safe therapeutic setting through clear structure, preparation, boundaries, attunement, environmental design, and ongoing attention to participant safety.
4 roles · 6 guidelines · 2 courses · 2 providers
5-MeO-DMTDMT / AyahuascaKetamine+2 moreCultural and spiritual sensitivity
Responds respectfully to spiritual, mystical, and value-related themes that may arise during psilocybin sessions and debriefing. Integrates these themes into therapy without imposing interpretations.
2 roles · 6 guidelines · 0 courses · 0 providers
IbogaineMDMAPsilocybinKetamine infusion monitoring
Cluster covering 5 related competencies including: Cardiac safety monitoring, Ketamine infusion monitoring, Ketamine infusion administration.
3 roles · 6 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+1 moreProfessional boundaries and recording consent
Therapists may record sessions only with explicit participant consent and must handle recordings for training and research within protocol limits. Recording is part of the therapeutic and scientific framework, not routine clinical use.
3 roles · 6 guidelines · 0 courses · 0 providers
5-MeO-DMTLSDMDMA+1 moreReproductive risk, contraception, and pregnancy monitoring
Teaches counseling and monitoring around contraception, reproductive restrictions, pregnancy risk, and pregnancy-related discontinuation rules. Learners are trained to explain requirements clearly and respond promptly when pregnancy or reproductive-safety concerns arise.
2 roles · 6 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+1 moreSafe treatment-setting facilitation
Provide a calm and supportive environment during treatment to reduce distress and support tolerance of the experience. The case report notes food, rest, and a quiet place as part of care.
2 roles · 6 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineMescalineTherapeutic rapport building
Cluster covering 4 related competencies including: Therapeutic rapport building, Rapport building and trust development, Therapeutic rapport and trust building.
2 roles · 6 guidelines · 0 courses · 0 providers
5-MeO-DMTLSDPsilocybinPsilocybin psychotherapy framework
Cluster covering 4 related competencies including: Psychedelic therapy workflow, Psilocybin psychotherapy framework, Psilocybin-assisted psychotherapy framework.
6 roles · 5 guidelines · 4 courses · 2 providers
DMT / AyahuascaKetaminePsilocybinEthical psychedelic facilitation
Cluster covering 3 related competencies including: Ethical psychedelic facilitation, Safe, legal psychedelic care facilitation, Ethical decision-making in psychedelic facilitation.
7 roles · 5 guidelines · 2 courses · 2 providers
5-MeO-DMTIbogaineKetamine+1 moreSession facilitation and therapeutic holding
Cluster covering 2 related competencies including: Session facilitation and therapeutic holding, Session facilitation and support during intense experiences.
3 roles · 5 guidelines · 2 courses · 2 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreManagement of concomitant medication interactions
Cluster covering 5 related competencies including: Concomitant medication review, Contraindication and interaction awareness, Contraindications, drug effects, and interactions.
4 roles · 5 guidelines · 1 courses · 1 providers
IbogaineLSDPsilocybinAssessment administration and interpretation
Ability to administer and interpret structured interviews, clinician ratings, and self-report measures used in the study. Therapists contribute to eligibility, safety, and outcome assessment.
2 roles · 5 guidelines · 0 courses · 0 providers
LSDPsilocybinKnowledge of PTSD and fear extinction theory
Understand the clinical and neurobehavioral rationale for PE and exposure-based treatment. The therapist should know how extinction learning is conceptualized in the study model.
2 roles · 5 guidelines · 0 courses · 0 providers
KetamineMDMAParticipant education and informed consent communication
Clinicians and research staff must clearly educate participants about study procedures, risks, side effects, restrictions, and possible benefits, and obtain written informed consent before screening and study participation. Ethical delivery depends on transparent communication and opportunities for questions.
2 roles · 5 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineKetamine+2 moreParticipant safety planning and support network coordination
Can identify and involve support persons, attendants, and outside providers to enhance safety. The facilitator must coordinate practical supports while respecting confidentiality and protocol boundaries.
3 roles · 5 guidelines · 0 courses · 0 providers
MDMAPsilocybinUnderstand dose-response and time course
The facilitator should know how oral and intravenous dosing relate to onset, duration, and peak effects. This knowledge supports proper session planning, monitoring, and integration timing.
2 roles · 5 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaLSD+3 moreProfessional self-care and burnout prevention
Teaches sustainable self-care practices for clinicians and facilitators working in emotionally intense settings. The competency supports emotional resilience, ethical boundaries, reflective practice, and burnout prevention.
5 roles · 4 guidelines · 3 courses · 3 providers
KetamineMDMAPsilocybinRisk evaluation and safety monitoring
Teaches continuous evaluation of clinical risk and maintenance of a safe care environment throughout preparation, dosing, and follow-up. Learners monitor risk signals, apply safety procedures, and escalate care when needed.
6 roles · 4 guidelines · 3 courses · 2 providers
5-MeO-DMTIbogaineKetamine+2 moreTherapeutic touch judgment
The training includes appropriate use of therapeutic touch as part of safe delivery. Learners are expected to use touch judiciously and within ethical boundaries.
4 roles · 4 guidelines · 1 courses · 1 providers
MDMAWorking with inner healing intelligence
The course teaches how to work with the 'Inner Healing Intelligence,' indicating a non-directive or facilitative stance toward client-led healing processes. This is framed as a core therapeutic concept in psychedelic work.
3 roles · 4 guidelines · 1 courses · 1 providers
MDMAControlled-substance handling awareness
Understands that MDMA is a Schedule 1 investigational product and must be stored, dispensed, and accounted for under regulatory control. Supports compliant handling during the session.
2 roles · 4 guidelines · 0 courses · 0 providers
KetamineMDMAPsilocybinDosage judgment and administration safety
Competent facilitation requires practical knowledge of dosage ranges, initial dosing, boosters, formulation handling, and administration errors. The handbook stresses both clinical judgment and meticulous procedural care.
2 roles · 4 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+1 moreManage agitation and elopement risk
Respond to agitation or attempts to leave the room in a way that preserves safety for the patient and others. The therapist should use containment, redirection, and escalation protocols when needed.
3 roles · 4 guidelines · 0 courses · 0 providers
5-MeO-DMTLSDMDMA+1 moreManagement of residual symptoms and re-entry
Therapists must prepare the subject for residual effects after the main session and provide practical safeguards for sleep, transportation, and home support. This includes framing recurrence of symptoms in a non-alarming way.
2 roles · 4 guidelines · 0 courses · 0 providers
5-MeO-DMTLSDMescalineMDMA administration oversight
Study clinicians are responsible for administering study drug, ensuring correct dose assignment, and supervising safe oral ingestion during blinded sessions. This includes verifying visit-specific randomization information and ensuring dosing is delivered under the blinded workflow.
2 roles · 4 guidelines · 0 courses · 0 providers
IbogaineMDMAMescalinePre-session dosing behavior instructions
Teaches clear communication of behavioral requirements before dosing sessions so conditions are standardized and preventable risks are reduced. Staff confirm that participants understand and follow pre-session instructions.
3 roles · 4 guidelines · 0 courses · 0 providers
KetaminePsilocybinPrioritize participant wellbeing over research aims
Participant safety and wellbeing must take precedence over scientific objectives at all times. Therapists must communicate and operationalize this priority throughout screening, treatment, and follow-up.
3 roles · 4 guidelines · 0 courses · 0 providers
DMT / AyahuascaMDMAPsilocybin psychoeducation
Cluster covering 2 related competencies including: Psilocybin psychoeducation, Psychedelic psychoeducation and expectation management.
2 roles · 4 guidelines · 0 courses · 0 providers
MDMAPsilocybinRespect for cultural and indigenous context
The use of ayahuasca requires sensitivity to its traditional indigenous and ceremonial origins. Facilitators should avoid reducing the practice to a purely technical intervention and should respect cultural meaning and ceremonial context.
2 roles · 4 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineCrisis and adverse-event response
The page signals training in managing difficult or high-risk moments, including crisis intervention and trigger management. Learners are expected to respond appropriately when a session becomes destabilizing or unsafe.
6 roles · 3 guidelines · 1 courses · 1 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreSafety monitoring and emergency awareness
The page points to checklists and a guide to basic medical emergencies, indicating that learners should be able to monitor safety and recognize urgent issues. The overall training context also stresses keeping both client and practitioner safe.
5 roles · 3 guidelines · 1 courses · 1 providers
DMT / AyahuascaIbogaineMDMAAttendant supervision and role clarity
Therapists must ensure attendants are appropriately selected and instructed for overnight monitoring. Attendants provide supportive care and observation without taking on psychotherapeutic functions.
3 roles · 3 guidelines · 0 courses · 0 providers
MDMABalance inner focus with communication
Therapists should support an appropriate rhythm between inward experiential focus and verbal interaction, with either therapist or participant able to initiate shifts.
2 roles · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineMDMAElicit and formulate positive intentions
Help the patient identify personally meaningful, positive intentions to guide the session and future change. Intentions should be active, concrete, and framed toward desired gains rather than avoidance.
2 roles · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTPsilocybinExpectation and expectancy management
Understand how treatment expectations can influence treatment response and study interpretation. Facilitation must avoid inadvertently shaping expectations in a biased or misleading way.
2 roles · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaInformed consent and treatment briefing
Therapists/facilitators must support ethically valid informed consent by ensuring participants understand the intervention, expectations, risks, and logistics. They also provide anticipatory guidance before ketamine sessions and discharge information after dosing.
2 roles · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineKetamineInformed consent responsibility
Facilitators are responsible for ensuring that participants have provided informed consent before receiving MDMA-assisted therapy. This reflects an ethical and regulatory duty central to work with investigational treatments.
2 roles · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaMDMAInformed preparation and orientation of the subject
The therapist is responsible for giving truthful, individualized preparation and reassurance about the experience, including likely sensations, risks of resistance, and expectations for conduct. The preparation aims to reduce fear, improve cooperation, and support voluntary participation.
2 roles · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaLSDInterdisciplinary coordination across mental health and medical services
Combined ketamine infusion and PE treatment requires coordination between psychotherapy providers and medical/anesthesia or medication administration staff. Effective collaboration supports timing, safety oversight, and protocol fidelity.
3 roles · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetamineKnowledge of ayahuasca pharmacology and effects
Understand the basic pharmacology and clinical effects of ayahuasca to inform safe facilitation and interpretation of responses. The source identifies dimethyltryptamine as a 5-HT2A agonist and harmine as a monoamine-oxidase A inhibitor.
2 roles · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaKnowledge of MDMA effects and risks
Facilitators must understand the expected psychological, physiological, and potential adverse effects of MDMA in order to prepare participants, support the session, and detect complications.
3 roles · 3 guidelines · 0 courses · 0 providers
MDMAMindfulness instruction
Facilitator can teach and cue mindfulness practices consistent with the study protocol. Mindfulness is presented as present-moment, nonjudgmental awareness.
2 roles · 3 guidelines · 0 courses · 0 providers
KetamineMDMAPsilocybinPractice nondirective, participant-led facilitation
A core competency is following rather than steering the participant’s process, intervening only in service of the unfolding inner-directed experience.
2 roles · 3 guidelines · 0 courses · 0 providers
MDMAPsilocybinProfessional qualifications and experience threshold
The manual specifies baseline professional requirements for study therapists. These include licensure and substantial clinical experience with psychiatric populations.
3 roles · 3 guidelines · 0 courses · 0 providers
MDMAPsilocybinPsychoeducation about MDMA effects and session trajectory
Therapists must understand MDMA’s expected subjective, interpersonal, and physiological effects and prepare participants accordingly. This knowledge supports normalization, reassurance, and effective use of the medicine within therapy.
2 roles · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaMDMAPsychological preparation and anxiety reduction
Facilitators need practical skills in preparing participants emotionally for ketamine administration and reducing distress. The protocol highlights relaxation, breathing, and grounding strategies to reduce anxiety or discomfort associated with the drug experience.
2 roles · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetaminePsychological state assessment
Administer and interpret psychological and psychometric measures relevant to mood, cravings, expectations, mystical experience, ego dissolution, and functioning. Facilitators must accurately support questionnaire-based assessment across time points.
2 roles · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaLSDMescaline+1 moreSetting optimization
Create an environment that supports safety, comfort, and relaxation during the session. The setting is deliberately structured to reduce anxiety and facilitate a positive experience.
2 roles · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaineSupport peak or mystical-type experiences without imposing them
Facilitators should be able to contain and make therapeutic use of profound emotional or peak experiences, including ego loosening, awe, reassurance, and feelings of unity or peace. The article suggests these experiences can be highly meaningful and therapeutic, but not all need to meet full mystical criteria.
2 roles · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTIbogaineLSDTherapeutic alliance and trust building
The therapist must create an atmosphere of confidence and mutual understanding before ketamine administration. This relationship is treated as a key therapeutic factor in the protocol.
1 role · 3 guidelines · 0 courses · 0 providers
IbogaineKetaminePsilocybinTherapeutic rapport and engagement support
Help patients engage in emotionally intense trauma-focused treatment and reduce dropout risk. The therapist should recognize comorbid depression or anxiety that may interfere with adherence and response.
2 roles · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetamineMDMATrauma treatment background
Therapists need a solid professional background in psychotherapy, especially PTSD treatment. Prior experience with established trauma therapies and related approaches is considered important preparation for this work.
2 roles · 3 guidelines · 0 courses · 0 providers
MDMAUnderstanding of trial procedures and schedule
Know the sequence, timing, and purpose of screening, preparation, dosing, scanning, follow-up, and unblinding visits. The therapist/facilitator must be able to work within the full protocol structure.
2 roles · 3 guidelines · 0 courses · 0 providers
MDMAPsilocybinUse clear, participant-centered communication
Therapists should communicate in language and nonverbal style the participant can readily follow, avoiding overly theoretical or confusing discourse.
2 roles · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTMDMAVirtual care facilitation
Capacity to conduct assessments and therapy sessions virtually when needed while preserving safety and confidentiality. The study permits telehealth sessions for certain visits and contingencies.
2 roles · 3 guidelines · 0 courses · 0 providers
KetaminePsilocybinHarm reduction and risk awareness
Cluster covering 5 related competencies including: Harm-reduction orientation, Harm reduction and risk awareness, Harm reduction for client support.
7 roles · 2 guidelines · 5 courses · 5 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreLegal and Regulatory Navigation
Teaches practitioners to identify and apply relevant legal, regulatory, ethical, and institutional requirements, including documentation, consent, reporting, controlled-substance, and jurisdiction-specific obligations.
6 roles · 2 guidelines · 2 courses · 2 providers
IbogaineKetamineMDMA+1 moreBasic life support
Learners are explicitly offered Basic Life Support training, indicating emergency readiness and medical safety preparation. The page notes DORA-required status, signaling regulatory safety relevance.
5 roles · 2 guidelines · 1 courses · 1 providers
5-MeO-DMTKetamineGuided inquiry and reflective language
Students learn to use language and questions that deepen a client’s inner experience and support healing. This is a practical communication competency for facilitation and integration work.
2 roles · 2 guidelines · 1 courses · 1 providers
LSDMDMAPsilocybinTherapist self-regulation
The curriculum explicitly includes therapist self-regulation as a therapeutic skill. This suggests learners are expected to maintain steadiness and presence while supporting clients in altered states.
4 roles · 2 guidelines · 1 courses · 1 providers
MDMAPsilocybinACT-based case formulation
Therapists must understand participant distress through an Acceptance and Commitment Therapy lens and use that formulation throughout preparation, dosing, and integration. They identify psychological inflexibility processes and track movement toward or away from psychological flexibility.
1 role · 2 guidelines · 0 courses · 0 providers
PsilocybinAssess and engage support systems
Therapists should understand the participant’s support network and appropriately involve support persons when relevant and desired.
2 roles · 2 guidelines · 0 courses · 0 providers
MDMAAssessment-driven therapeutic tailoring
Uses assessment findings to individualize therapy and medication-session preparation. Adapts the approach based on participant response, goals, and clinical presentation.
1 role · 2 guidelines · 0 courses · 0 providers
KetaminePsilocybinCeremonial framing and intentional therapeutic setting
Facilitators require skill in establishing ceremonial and intentional framing around ketamine sessions to support therapeutic depth and coherence. This includes preparing participants for the significance and structure of the experience within the group model.
1 role · 2 guidelines · 0 courses · 0 providers
KetamineCompetence in protocol adherence for dosing sessions
The intervention involved two separate psilocybin dosing sessions 3 weeks apart under a randomized controlled protocol, implying the need for facilitators to reliably support treatment according to a fixed schedule and study procedures.
2 roles · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaPsilocybinConduct qualitative, client-centered inquiry
Facilitators/research therapists should be able to elicit and understand patients’ subjective experience from a client-centered perspective. The study used semi-structured interviews focused on experience, anxiety, quality of life, and values.
2 roles · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaLSDCoordinate with outside providers ethically
Therapists must coordinate with prescribing clinicians and existing psychotherapists when relevant, while respecting consent and confidentiality. Communication should support safety, continuity, and protocol integrity.
4 roles · 2 guidelines · 0 courses · 0 providers
MDMACultural and language competence for participation
Staff must ensure participants can understand and engage with the protocol in the site’s recognized language and can participate in a way that preserves safety and informed consent. This is part of the practical knowledge needed for ethical facilitation.
2 roles · 2 guidelines · 0 courses · 0 providers
MDMADeliver mindfulness and grounding exercises
Use brief mindfulness practices and grounding strategies to stabilize attention and reduce distress before and during the session. These techniques help the patient reconnect to present-moment awareness and bodily sensation.
2 roles · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaPsilocybinEmpathic presence and active listening
Therapists are expected to provide consistent empathic presence, nonjudgmental attunement, and deep listening throughout the process. This includes validating feelings, listening for deeper meaning, and creating psychological permission for openness.
2 roles · 2 guidelines · 0 courses · 0 providers
IbogaineMDMAExperience with altered states of consciousness
Facilitators are expected to have substantial prior experience supporting altered states of consciousness. This experience supports containment, trust, and skilled response to unusual perceptual and emotional phenomena.
2 roles · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaGroup facilitation and relationship management
When leading group sessions, therapists must manage group size, relational instability, empathic bonds, exclusion dynamics, and mutual support among therapists. The handbook treats group structure as a clinically important variable.
1 role · 2 guidelines · 0 courses · 0 providers
5-MeO-DMTLSDMaintain beginner’s mind
Therapists should cultivate openness about both the participant’s process and their own interpretations. This prevents forcing experience into rigid theoretical frames and supports curiosity and compassion.
2 roles · 2 guidelines · 0 courses · 0 providers
MDMAManagement of assessment-related distress
Because interviews and questionnaires may provoke emotional reactions or fatigue, facilitators must respond supportively and mitigate burden. This includes addressing distress during assessments and offering breaks.
2 roles · 2 guidelines · 0 courses · 0 providers
MDMAPsilocybinMotivational enhancement for quitting
Elicit and strengthen motivation to quit smoking and remain abstinent. Facilitators use sessions to explore values, reasons for quitting, and treatment commitment.
2 roles · 2 guidelines · 0 courses · 0 providers
KetaminePsilocybinMotivational interviewing and enhancement
Uses motivational interviewing methods to strengthen intrinsic motivation and commitment to change. Tailors discussions to the participant’s ambivalence, goals, and readiness to change drinking behavior.
2 roles · 2 guidelines · 0 courses · 0 providers
KetaminePsilocybinNausea and vomiting management
Recognize and respond to gastrointestinal adverse effects that may occur frequently with higher doses. Manage emesis to reduce aspiration risk, dehydration, and treatment disruption.
2 roles · 2 guidelines · 0 courses · 0 providers
MescalineIbogaineOptional biomarker/genomic research handling
Understands the optional nature and operational limits of biomarker and pharmacogenomic collection. Ensures consent, timing, fasting guidance, and sample handling requirements are respected.
2 roles · 2 guidelines · 0 courses · 0 providers
KetamineMescalinePreparation for altered-state experience
A major therapist competency is preparing patients extensively for the ketamine session, including the nature of the special state of consciousness and possible ego dissolution or separation from the body. Preparation is both educational and psychotherapeutic.
1 role · 2 guidelines · 0 courses · 0 providers
KetamineMDMAProtection against coercion and dual-role influence
The protocol explicitly addresses the risk of undue influence when investigators recruit current or former patients, requiring safeguards and ongoing monitoring for coercion.
2 roles · 2 guidelines · 0 courses · 0 providers
MDMARespiratory monitoring
Facilitators must watch for slowed breathing, sleep apnea-related hypoxia, disordered breathing, and oxygen desaturation. Oxygenation needs ongoing assessment during the acute and post-acute periods.
2 roles · 2 guidelines · 0 courses · 0 providers
IbogaineRetention and engagement skills
Given the risk of high attrition, facilitators need strong engagement and follow-up skills. The protocol explicitly notes the importance of respecting time commitments, tracking procedures, and strong interpersonal skills of study personnel.
1 role · 2 guidelines · 0 courses · 0 providers
5-MeO-DMTKetamineRisk-benefit judgment
Balances potential symptom relief against known and emerging safety risks in participants with opioid dependence. Makes conservative decisions when cardiac or adverse-effect concerns outweigh anticipated benefit.
2 roles · 2 guidelines · 0 courses · 0 providers
IbogaineSafety oversight and independent review
Clinical investigators must work within independent safety monitoring structures and avoid conflicts in oversight roles. Therapists/facilitators in research settings should support scheduled review of participant safety outcomes.
2 roles · 2 guidelines · 0 courses · 0 providers
5-MeO-DMTMDMAStress inoculation and breathwork instruction
At least one therapist must be able to teach stress inoculation methods, especially diaphragmatic breathing, and apply breath-based interventions during sessions. Breath is used both for relaxation and for staying present with difficult experience.
2 roles · 2 guidelines · 0 courses · 0 providers
5-MeO-DMTMDMATherapist availability and time commitment
Therapists must be prepared for an extensive and sometimes unpredictable commitment of time and support. Ethical delivery includes reliable availability beyond scheduled sessions when participants need additional help.
1 role · 2 guidelines · 0 courses · 0 providers
LSDMDMATraining in PAP and protocol manual adherence
Therapists must be specifically trained in psilocybin-assisted psychotherapy and in the study’s manualized procedures. Competence includes familiarity with the therapeutic model and difficult-state management guidance.
2 roles · 2 guidelines · 0 courses · 0 providers
PsilocybinTreatment-condition matching and support
Deliver comparable behavioral support across psilocybin and NRT conditions while respecting protocol differences. Facilitators must maintain treatment fidelity and avoid bias toward one arm.
2 roles · 2 guidelines · 0 courses · 0 providers
KetaminePsilocybinUnderstanding MDMA effects and non-linear healing
Therapists must have a thorough understanding of MDMA’s subjective, relational, and physiological effects, including the non-linear way these may support healing. This knowledge is necessary for preparation, in-session decisions, and normalization of participant experiences.
2 roles · 2 guidelines · 0 courses · 0 providers
MDMAUse of ACT and adjunctive psychotherapies
Apply Acceptance and Commitment Therapy as the primary psychotherapeutic framework, while using other modalities as clinically indicated. The protocol also references CBT, psychodynamic approaches, and Internal Family Systems.
1 role · 2 guidelines · 0 courses · 0 providers
KetaminePsilocybinValues clarification and committed action coaching
Therapists must help participants identify, recover, and translate values into concrete behavior change. The manual treats values work as central to depression recovery and integration.
2 roles · 2 guidelines · 0 courses · 0 providers
PsilocybinWork with bodily sensations and somatic process
Therapists should orient to and explore the participant’s somatic experience, both in experimental and integrative sessions, as a central channel of processing.
2 roles · 2 guidelines · 0 courses · 0 providers
MDMAWork with psychodynamic material
Therapists need knowledge of psychodynamic processes likely to arise under LSD, including emergence of previously excluded material, abreaction, catharsis, and memory-rich reliving of past experiences. The discussion explicitly identifies these as mechanisms relevant to treatment.
2 roles · 2 guidelines · 0 courses · 0 providers
LSDWorking with family/collateral supports
The protocol expects involvement of relatives in follow-up, indicating a facilitator competency in engaging collateral supports. This helps verify outcomes and sustain recovery monitoring.
2 roles · 2 guidelines · 0 courses · 0 providers
IbogaineKetaminePsychedelic research literacy and evidence appraisal
Teaches how to interpret the psychedelic clinical evidence base, compare strength of evidence across indications, understand mechanism theories, and critically appraise research claims. The competency supports evidence-informed practice rather than relying on general field narratives.
7 roles · 1 guidelines · 11 courses · 8 providers
IbogaineKetamineLSD+2 moreTrauma-informed care
Cluster covering 2 related competencies including: Trauma-informed care, Trauma-informed psychedelic care.
4 roles · 1 guidelines · 4 courses · 4 providers
KetaminePsilocybinProfessional Scope and Practice Alignment
Teaches clinicians to recognise their role boundaries, align services with training, licensure, supervision, and organisational policy, and refer or escalate when participant needs fall outside their scope of competence.
6 roles · 1 guidelines · 3 courses · 2 providers
IbogaineMDMAPsilocybinPharmacology, contraindications, and interaction awareness
Teaches psychoactive substance pharmacology, expected drug effects, contraindications, and relevant drug-interaction risks. The competency supports safer screening, medication review, participant education, and clinical decision-making.
6 roles · 1 guidelines · 2 courses · 2 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 morePsychotherapeutic facilitation methods
Cluster covering 2 related competencies including: Facilitation of psychedelic journeys, Psychotherapeutic facilitation methods.
4 roles · 1 guidelines · 2 courses · 2 providers
LSDPsilocybinPsychedelic harm reduction and integration fundamentals
Cluster covering 2 related competencies including: Psychedelic harm reduction and integration therapy, Psychedelic harm reduction and integration fundamentals.
5 roles · 1 guidelines · 2 courses · 1 providers
KetamineLSDMDMA+1 moreTrauma-informed practice
Cluster covering 2 related competencies including: Trauma-informed practice, Trauma-informed clinical practice.
2 roles · 1 guidelines · 2 courses · 1 providers
MDMAPsilocybinConfidentiality and trust maintenance
The course explicitly discusses confidentiality, especially in underground practice and with anonymous practitioners. Learners are expected to understand confidentiality as a core part of maintaining safe and effective psychedelic care relationships.
4 roles · 1 guidelines · 1 courses · 1 providers
LSDUse of adjunctive therapeutic modalities
Advanced trainings mention topics like IFS, art therapy, breathwork, and integration, implying learners can deepen their practice with complementary methods. These are presented as continuing development topics rather than core prerequisites.
2 roles · 1 guidelines · 1 courses · 1 providers
IbogaineAppropriate facilitator qualifications
Lead facilitators were doctoral-level psychologists or physicians with major depressive disorder treatment experience, and co-facilitators had at least a bachelor’s degree in a mental health-related field. The source therefore indicates role-appropriate clinical background and experience requirements.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinAssess and prepare social support
Therapists should evaluate the participant’s support network and help plan how supports can assist between sessions. They must also guide participants about the benefits and risks of disclosing their experiences to others.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMAAssessment of psychological readiness and vulnerability
Before administration, facilitators should assess readiness and factors that could increase the chance of a difficult session. The source highlights that preoccupation, rigidity, low trust, and poor support can worsen experiences.
2 roles · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTAuthenticity and trustworthiness
Facilitators should present as authentic, relatable, and trustworthy, and be open to participant questions and feedback. Establishing a credible and safe relational basis is part of responsible practice.
2 roles · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTAwareness of interaction and formulation cautions
The therapist/facilitator must understand potential drug-interaction concerns and formulation-related differences that could alter tolerability or safety. The source mentions caution with antiemetics and alternative preparations.
2 roles · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaAyahuasca pharmacology and dosing awareness
Facilitators need basic knowledge of ayahuasca composition, dosing, and interaction risks to support safe administration. The protocol emphasizes dose calculation, substance composition, and monitoring for contraindications.
1 role · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaBoundary management in a dual-role therapeutic model
Navigate the combination of psychedelic support and AUD therapy while preserving clear therapeutic boundaries. The facilitator must deliver supportive care without role confusion or undue influence.
2 roles · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaCBT expertise for mood disorders
Clinicians must have working expertise in evidence-based CBT for depression and related mood conditions, including the ability to deliver core CBT components across preparation, post-session integration, and relapse prevention phases. The protocol assumes competence in standard CBT delivery as the psychosocial backbone of treatment.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinCognitive-behavioral smoking cessation counseling
Deliver structured CBT-based smoking cessation support throughout the trial. Facilitators teach practical self-management strategies before and after the target quit date.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinCollaboration with medical and nursing staff
Ketamine-assisted treatment in this protocol is multidisciplinary, so facilitators must work closely with study doctors and nurses. This includes coordinating preparation, understanding monitoring responsibilities, and escalating concerns appropriately.
1 role · 1 guidelines · 0 courses · 0 providers
KetamineCollaboratively address trauma material
Therapists should obtain agreement that trauma may be gently brought up if not spontaneously addressed, while preserving participant choice and collaborative exploration.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMACommunity network and sustainability building
Responsible practitioners cultivate relationships with other practitioners and community networks to support sustainable care. They help build systems that expand access while preserving integrity and safety.
2 roles · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTCompetence with open-label continuation procedures
Understand the transition from blinded randomized treatment to open-label MDMA-assisted therapy for eligible participants. This includes separate consent, revised scheduling, and altered assessment timing.
1 role · 1 guidelines · 0 courses · 0 providers
MDMAControlled inhalation administration
Can safely administer vaporized GH001 using standardized equipment and procedure. Accurate delivery and participant instruction are essential to reliable dosing.
2 roles · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTCultivate beginner’s mind
Therapists should encourage participants to set aside rigid expectations and remain open to whatever arises during experimental sessions.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMACultural and values-sensitive therapy
Explores participant values, including spiritual values, in a respectful way that supports behavior change. Integrates meaning-making without imposing therapist beliefs.
1 role · 1 guidelines · 0 courses · 0 providers
PsilocybinCultural humility and adaptation of ACT language
Adapt therapy language and mindfulness practices to fit participants' cultural, spiritual, and social contexts. The manual emphasizes that ACT concepts may need careful framing to avoid invalidation or misunderstanding.
1 role · 1 guidelines · 0 courses · 0 providers
PsilocybinElicit expectations, fears, and concerns
Therapists should proactively explore participants’ hopes, fears, concerns, and expectations about treatment and address them responsively.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMAEmergency response readiness
Be prepared to recognize medical deterioration and summon emergency help immediately. The manual states that providers who cannot call for emergency assistance should not provide ibogaine therapy.
1 role · 1 guidelines · 0 courses · 0 providers
IbogaineEthical data handling
Responsibility to use study information appropriately and in accordance with registry expectations. This includes respecting the limits of what can be inferred from the record text alone.
2 roles · 1 guidelines · 0 courses · 0 providers
IbogaineEthical handling of participant communication about future research
Manage optional future-contact procedures ethically and separately from current study participation. Participants may choose whether to authorize future contact without affecting present enrollment decisions.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinEthical honesty and transparency in management
The handbook emphasizes straightforward, honest dealing with subjects, especially when they feel suspicious, followed, or influenced. Trust is built by avoiding manipulation, deception, or concealed motives.
1 role · 1 guidelines · 0 courses · 0 providers
LSDEthical purpose and intention setting
Organizers should clarify the purpose of the session and the ethical means of achieving it. They should also encourage participants to prepare an intention in an ethical and responsible way.
2 roles · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaEthical risk communication
Communicates the experimental and unregulated nature of ibogaine treatment honestly. The source highlights an ibogaine subculture offering unregulated preparations, which creates an ethical duty to disclose uncertainty and risks.
2 roles · 1 guidelines · 0 courses · 0 providers
IbogaineEthical use of psychoactive substances in therapy
Responsibility to use LSD only within an ethically justified, clinically supervised framework. The source does not specify safeguards, but the therapeutic use of a potent psychoactive substance requires careful ethical oversight.
1 role · 1 guidelines · 0 courses · 0 providers
LSDEthical use of trial information
Uses publicly available trial information responsibly and within its intended scope. Respects that registry content is not a substitute for clinical judgment, consent procedures, or study-specific training.
2 roles · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaExistential psychotherapy orientation
The therapist needs knowledge of existentially oriented psychotherapy and how to apply it in addiction treatment. The protocol explicitly frames KPT around meaning, values, self-concept, and life purpose.
1 role · 1 guidelines · 0 courses · 0 providers
KetamineExplain likely effects of MDMA
Therapists should prepare participants by describing common psychological and physiological effects of MDMA and emphasizing variability of response.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMAIdentity and values reconstruction
Facilitators must support the bereaved person in rebuilding identity and future orientation after loss. The protocol uses values clarification to help participants orient life around their own goals and surviving self.
2 roles · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaInform participants of new safety-relevant findings
Investigators have a continuing duty to inform participants about new findings regarding LSD or LSD-assisted therapy that emerge during the study. This reflects an ongoing consent responsibility rather than a one-time disclosure.
1 role · 1 guidelines · 0 courses · 0 providers
LSDInformed consent administration
Therapists/facilitators must ensure participants are properly informed using approved consent materials before participation in MDMA-assisted psychotherapy research.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMAInformed consent and ethical use in uncertain evidence
Use ibogaine only after a careful discussion of uncertain efficacy, limited research, and known risks. Ethical practice requires transparent communication about the experimental nature of treatment and the absence of robust clinical standards.
2 roles · 1 guidelines · 0 courses · 0 providers
IbogaineInformed consent and experimental-treatment disclosure
Clearly explain the investigational nature of ibogaine treatment and its known serious risks before treatment begins. Ethical practice requires that patients understand both uncertain benefits and significant safety concerns.
2 roles · 1 guidelines · 0 courses · 0 providers
IbogaineInformed consent boundary awareness
Study personnel involved with participants must understand informed consent responsibilities and boundaries. Consent is an ongoing process, and appropriately trained staff without an existing clinical relationship obtain consent, not the PI.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinInterprofessional coordination and referral management
Safe delivery requires coordination among therapists, physicians, nurses, blinded assessors, outside therapists, and emergency services.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMAIntoxication assessment before preparation
Determine whether a patient is intoxicated enough to impair participation in preparation sessions. This requires clinical judgment focused on comprehension and therapeutic alliance.
1 role · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaKnowledge of ayahuasca and traditional Amazonian medicine
Understands the therapeutic role of ayahuasca as a psychoactive plant brew used ritually in traditional Amazonian medicine. Knowledge of the cultural and medicinal context is necessary to support safe and appropriate facilitation.
2 roles · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaKnowledge of psychedelic session structure
Facilitators need to understand the full treatment sequence and how each phase contributes to safety and treatment delivery. The intervention depends on correct sequencing and timing.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinKnowledge of risks and benefits of MDMA-assisted therapy
Clinicians need working knowledge of the potential risks and benefits of MDMA-assisted therapy as the research is designed to explore both. This knowledge supports informed consent, clinical judgment, and participant monitoring.
1 role · 1 guidelines · 0 courses · 0 providers
MDMALegal awareness
Those organizing sessions should understand the legal implications of ayahuasca in their jurisdiction. This helps them manage accountability and reduce legal risk.
2 roles · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaMaintain a post-session safety net
Therapists must provide continuity, availability, and clear support structures after MDMA sessions to reduce anxiety and manage emerging difficulties. This safety net extends beyond the dosing day.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMAManagement of dual relationships and undue influence
Therapists must protect voluntariness when potential participants are also their patients. Independent evaluation should be used to reduce pressure or perceived coercion in recruitment and consent.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMAManaging short-duration high-intensity sessions
5-MeO-DMT produces a very short but intense experience, which changes facilitation demands. Facilitators must be prepared for rapid transitions into and out of the altered state.
1 role · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaMeaning reconstruction therapy delivery
Therapists must competently deliver the 9-session meaning reconstruction protocol for grief, including its event story, back story, and personal story phases. The work is aimed at helping bereaved participants make sense of the loss, revise attachment-related meanings, and reconstruct identity and future orientation.
1 role · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaMonitoring depressive aftermath and unmet integration
The therapist should watch for depression after the experience, particularly when insights are not translated into action. Continued support is presented as a way to reduce this risk and restore constructive orientation.
1 role · 1 guidelines · 0 courses · 0 providers
LSDOngoing informed consent
Treat consent as a continuing process rather than a one-time event. Patients must understand the treatment and retain the ability to revoke consent, with special procedures during the medication session for safety.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMAParanoia and psychotomimetic state management
The therapist must recognize confusion, paranoia, referential thinking, withdrawal, or grandiosity and respond with steady trust, containment, and continued presence. Management skill is particularly important because these reactions may still be workable and may shift with proper handling.
1 role · 1 guidelines · 0 courses · 0 providers
LSDParticipant preparation and procedural guidance
Prepare participants for the dosing session and guide them through standardized procedures. The facilitator should ensure readiness, adherence to study rules, and smooth progression through the session schedule.
1 role · 1 guidelines · 0 courses · 0 providers
MescalineParticipant preparation for medication adherence
Prepare participants to correctly use nicotine replacement therapy when assigned to the control arm. Facilitators must provide education, dosing instructions, and side-effect guidance.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinPreparation for ketamine sessions
Therapists must prepare participants psychologically and practically for ketamine dosing through rapport-building, psychoeducation, expectation-setting, and intention development. Preparation is emphasized because of trauma burden, psychiatric comorbidity, and instability in the target population.
1 role · 1 guidelines · 0 courses · 0 providers
KetamineProfessional training in human subjects research
Expectation that study personnel are trained in research ethics and responsible conduct of research. This underpins appropriate consent, confidentiality, and participant safety practices.
2 roles · 1 guidelines · 0 courses · 0 providers
KetamineProvide protocol-consistent patient education and informed framing
Clinicians should present the intervention accurately as ketamine- or midazolam-augmented PE within a research protocol, with clear explanation of purpose and expectations. Ethical practice includes avoiding overstatement of benefit and framing treatment as investigational augmentation of an established therapy.
1 role · 1 guidelines · 0 courses · 0 providers
KetaminePsychedelic pharmacology and interaction awareness
Understand the pharmacology and interaction risks of 5-MeO-DMT/BPL-003, including serotonergic and cardiovascular concerns. This knowledge informs safe preparation, exclusion screening, and monitoring.
2 roles · 1 guidelines · 0 courses · 0 providers
DMT / Ayahuasca5-MeO-DMTRelapse-prevention support
Help patients navigate craving, relapse risk, and post-treatment vulnerability. The manual notes that fear of relapse is more realistic than fear of withdrawal after ibogaine.
2 roles · 1 guidelines · 0 courses · 0 providers
IbogaineRelational field attunement
Attend closely to the therapeutic relationship as an active part of the healing process. IMAP treats the relational field as a primary site where trauma, repair, trust, and connection unfold.
1 role · 1 guidelines · 0 courses · 0 providers
MDMAResearch visit scheduling and follow-up coordination
Coordinate multi-visit assessment timelines around the psilocybin session. Follow-up data collection is essential for longitudinal outcomes and requires careful scheduling.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinRisk education and expectation setting
Can explain common, psychological, and severe risks of KAP in understandable terms. Sets realistic expectations that outcomes may vary and are not guaranteed.
2 roles · 1 guidelines · 0 courses · 0 providers
KetamineRoute-specific administration awareness
Facilitators need working knowledge of administration routes because onset, duration, intensity, and tolerability vary substantially. This informs preparation, monitoring, and participant education.
2 roles · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaSet shaping and mindset influence
The facilitator influences the participant’s mindset through tone, language, responsiveness, and overall presence. They should intentionally support a conducive mental set from first contact through post-session care.
1 role · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTShort-duration session management
The facilitator should be able to manage a brief but intense treatment window. The source suggests a shorter-acting psychedelic may enable rapid onset of response and reduce burden compared with longer-acting agents.
1 role · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTSocial support assessment and guidance
Therapists must assess the participant’s social support network and help plan appropriate use of supportive relationships during treatment. They should guide participants about the potential benefits and risks of sharing their experiences with others.
1 role · 1 guidelines · 0 courses · 0 providers
MDMASupport for repeated-session care planning
Because the protocol compares single versus repeated KPT, therapists must be able to prepare patients for sequential sessions and maintain continuity across a month-spaced treatment course. This includes pre-session counseling and repeated integration work.
1 role · 1 guidelines · 0 courses · 0 providers
KetamineSupport relationship and support-system integration
Therapists must help participants navigate interpersonal shifts, disclosure decisions, and support-system responses during healing. They should anticipate misunderstanding, family-system changes, and new relational capacities.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMATask instruction and coaching
Prepare participants to complete emotional processing tasks and questionnaires accurately. Staff must teach task procedures and ensure participants understand expectations before scanning and follow-up assessments.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinTherapist qualification and prior KAP experience
Therapists should meet formal licensure requirements and have specific prior training and experience in ketamine-assisted psychotherapy. Competence is not generic psychotherapy alone but includes psychedelic/ketamine-specific preparation and familiarity with the study population.
1 role · 1 guidelines · 0 courses · 0 providers
KetamineTrauma-informed, non-threatening interviewing
Use a caring, natural, and non-threatening interview style to assess psychiatric and psychological domains. The protocol emphasizes normalization, reduction of guilt, symptom exaggeration techniques, and a logical flow that facilitates rapport.
2 roles · 1 guidelines · 0 courses · 0 providers
KetamineUnderstanding of study schedule and visit procedures
Facilitators must know the study timeline to conduct therapy and safety checks at the correct times. They should understand which visits are in person, virtual, or questionnaire-only and what assessments occur at each stage.
1 role · 1 guidelines · 0 courses · 0 providers
PsilocybinUse of cognitive and behavioral assessment domains
Understand the domains assessed in the Storyline psychiatric and neurological interviews and use this knowledge to support accurate administration and interpretation of study tasks. Domains include cognition, mood, homeostasis, social support, and psychosis/suicidality screening.
2 roles · 1 guidelines · 0 courses · 0 providers
KetamineUse of discussion to consolidate insight
Once stabilization is achieved, the therapist should help the subject translate diffuse feeling states into articulated ideas without imposing doctrinal answers. Discussion is used to deepen learning, interpersonal understanding, and future application.
1 role · 1 guidelines · 0 courses · 0 providers
LSDUse self-directed enquiry
Help participants direct attention to their own present-moment internal experience and explore it from multiple perspectives. This is practiced in preparation and used to support participants if challenging material emerges during dosing.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinValidate affirming experiences as healing
Therapists should validate positive, affirming, and resourcing experiences as meaningful components of healing, growth, and meaning-making.
1 role · 1 guidelines · 0 courses · 0 providers
MDMAValidate difficult experiences as healing
Therapists should frame difficult emotions, challenging material, and distressing experiences as potentially meaningful parts of healing rather than signs of failure.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMACase-based practice, peer consultation, and professional learning community
Teaches applied competence through role play, case discussion, peer consultation, seminars, mentorship, and learning-community structures. The emphasis is translating theory into practice, receiving feedback, and developing reflective clinical judgment with peers.
7 roles · 0 guidelines · 8 courses · 7 providers
KetaminePsilocybinPsychedelic therapy foundation
Cluster covering 7 related competencies including: Psychedelic therapy foundation, Psychedelic therapy foundations, Psychedelic practice fundamentals.
7 roles · 0 guidelines · 6 courses · 5 providers
KetamineMDMAPsilocybinNeurobiology of non-ordinary states
Teaches the neurobiological basis of psychedelic and non-ordinary states, including default mode, salience, fear, and related brain-network models. The competency links altered-state phenomenology with therapeutic mechanisms and clinical implications.
4 roles · 0 guidelines · 4 courses · 4 providers
KetaminePsilocybinEthics and ethical practice
Cluster covering 4 related competencies including: Ethical practice, Ethics in psychedelic care, Ethics and ethical practice.
6 roles · 0 guidelines · 4 courses · 3 providers
MDMAPsilocybinClinical protocol literacy
Teaches practitioners to read and understand clinical protocols, treatment manuals, and evidence-based psychedelic care procedures. The focus is knowing how protocol requirements shape preparation, dosing, integration, documentation, and safety responsibilities.
6 roles · 0 guidelines · 2 courses · 2 providers
KetamineMDMAPsilocybinExperiential Learning and Reflective Practice
Teaches practitioners to use experiential exercises, embodied awareness, supervision, and structured self-reflection to examine their own reactions, assumptions, limits, and relational patterns in clinical work.
3 roles · 0 guidelines · 2 courses · 2 providers
Preparation and therapeutic alliance
Cluster covering 2 related competencies including: Preparation and therapeutic alliance, Preparation and therapeutic alliance building.
3 roles · 0 guidelines · 2 courses · 2 providers
Professional application and practice development
Teaches practitioners how to translate psychedelic-informed training into professional practice, including applied skill development, scope awareness, practice-building considerations, and integration of competencies into real clinical or wellness settings.
5 roles · 0 guidelines · 2 courses · 2 providers
Complex-case support and ethics-based clinical judgment
Teaches work with clinically complex contexts such as trauma, palliative care, and other nuanced presentations where ethical judgment, scope discipline, careful assessment, and individualized support are required.
4 roles · 0 guidelines · 2 courses · 1 providers
PsilocybinLegal access pathways and care-team coordination
Teaches how participants move through lawful access routes and coordinated care pathways. The competency covers referral navigation, team handoffs, and the practical steps needed to connect eligible participants with appropriate treatment or study settings.
6 roles · 0 guidelines · 2 courses · 1 providers
MDMAPsilocybinPsilocybin prescribing fundamentals
Cluster covering 2 related competencies including: Psilocybin prescribing fundamentals, Prescribing fundamentals for psychedelic treatment.
2 roles · 0 guidelines · 2 courses · 1 providers
MDMAPsilocybinActive guiding and purposeful intervention
The course also teaches a more active guiding style, especially through Ralph Metzner’s approach, where guides may introduce focused inquiries, somatic practices, or other interventions. Learners are shown how interventions can shape the trajectory of a session when used skillfully.
3 roles · 0 guidelines · 1 courses · 1 providers
Apprenticeship and mentor shadowing
The program includes supervised apprenticeship hours with pre-approved mentors. Learners are expected to observe, assist, and translate training into supervised practice.
4 roles · 0 guidelines · 1 courses · 1 providers
PsilocybinAssessment and intake
The curriculum includes practical assessment work and use of intake templates and assessment forms. Students learn to evaluate client fit and tailor support based on client goals and needs.
3 roles · 0 guidelines · 1 courses · 1 providers
Clinical documentation and coordination
Some listed programs explicitly teach clinical documentation and related practice management skills. This suggests learners may be expected to document care, coordinate treatment processes, and work within structured clinical workflows.
3 roles · 0 guidelines · 1 courses · 1 providers
KetamineMDMAPsilocybinClinical trial training and feedback use
The page highlights best-in-class clinical training for drug trials and AI-supported evaluation. Learners are expected to refine skills quickly and receive targeted feedback in training or evaluation contexts.
6 roles · 0 guidelines · 1 courses · 1 providers
Collaborative work with adjunctive clients
Learners are taught how to work with clients who already have an outside therapist and to coordinate closely with existing treatment. The course also mentions treatment flow for groups and couples.
3 roles · 0 guidelines · 1 courses · 1 providers
KetamineCollaborative-care role awareness
The program emphasizes that it prepares people for therapeutic and facilitative roles within a collaborative care framework, not independent medical practice. Learners are expected to understand role boundaries, especially around prescribing and administration.
5 roles · 0 guidelines · 1 courses · 1 providers
KetaminePsilocybinCompound comparison for therapeutic use
The course teaches learners to distinguish between classic psychedelics and emerging therapies within therapeutic applications. This is a foundational comparative literacy competency rather than a protocol-specific skill.
6 roles · 0 guidelines · 1 courses · 1 providers
KetamineLSDMDMA+1 moreContemplative practice support
Contemplative practice is included as a core domain, suggesting learners are exposed to practices that support presence, reflection, and self-regulation in facilitation work. This likely supports both practitioner preparation and client-facing care.
3 roles · 0 guidelines · 1 courses · 1 providers
Coordination and documentation using checklists and manuals
The page repeatedly points learners to manuals, checklists, PDFs, and reference materials, indicating a practical emphasis on coordination and structured preparation. This suggests learners should be able to organize session materials and support process consistency.
4 roles · 0 guidelines · 1 courses · 1 providers
Debriefing and reflective practice
The practicum includes retreat team debriefs, supervisor meetings, and assessment presentations. This signals an expectation that learners can reflect on practice, receive feedback, and integrate learning.
5 roles · 0 guidelines · 1 courses · 1 providers
Ethical and equitable practice
Learners are expected to follow the North Star Ethics Pledge and practice non-discrimination, equity, and inclusion. Ethical responsibility is positioned as a core professional competency.
4 roles · 0 guidelines · 1 courses · 1 providers
PsilocybinHuman-centred, experiential facilitation
The overall program emphasizes experiential, relational, and community-grounded learning, including retreat and practicum components. Learners are expected to develop a grounded facilitation presence in addition to theory.
3 roles · 0 guidelines · 1 courses · 1 providers
MDMAPsilocybinLeadership and coaching presence in expanded states
Faculty and program structure emphasize leadership, coaching presence, and personal transformation as part of practitioner development. Students are expected to become more skillful in guiding high-achieving and growth-oriented clients.
3 roles · 0 guidelines · 1 courses · 1 providers
Mentorship and professional development
Each trainee works with a mentor, and mentoring includes professional development discussions, role plays, and networking. This indicates structured support for building practice readiness and professional identity.
4 roles · 0 guidelines · 1 courses · 1 providers
Microdosing and macrodosing protocol design
Learners are taught to design custom protocols for both microdosing and macrodosing based on client goals. The page also references microdosing formulas and practical application of timing and dosage nuances.
3 roles · 0 guidelines · 1 courses · 1 providers
PsilocybinObserving and holding space without reacting
Learners are expected to develop the ability to witness clients and processes calmly, without overreacting or trying to control the experience. The course explicitly frames this as foundational to practitioner development.
4 roles · 0 guidelines · 1 courses · 1 providers
Peer consultation and collaborative learning
Vital emphasizes study groups, peer interaction, and faculty-led sessions. Learners are expected to collaborate with others, receive feedback, and improve their practice through community learning.
4 roles · 0 guidelines · 1 courses · 1 providers
Personal growth work and self-exploration
Students are expected to complete personal growth work outside the program, including therapy, guided entheogenic work, or meditation retreats. This signals the importance of self-awareness and personal preparation for facilitation work.
2 roles · 0 guidelines · 1 courses · 1 providers
PsilocybinProfessional identity and licensing readiness
The page repeatedly frames the program as preparing learners for licensure and professional practice in Oregon. Learners are expected to understand practice context, licensure requirements, and professional transitions.
4 roles · 0 guidelines · 1 courses · 1 providers
PsilocybinSafety-oriented documentation and templates
Trainees receive templates such as consent and intake forms, informational documents, and guidelines, which implies competence in using standardized practice materials. The page also signals procedural support for safe and organized care delivery.
5 roles · 0 guidelines · 1 courses · 1 providers
KetamineSafety, ethics, and responsibility in expanded states work
The course explicitly states that facilitators are guided in safety, ethics, and responsibility. Learners are expected to recognize and manage the unique risks of working with altered states.
3 roles · 0 guidelines · 1 courses · 1 providers
PsilocybinSpace preparation and ceremonial setup
Practicum hours may include operational tasks like preparing rooms, setting up altars, and arranging ceremonial spaces. These are treated as part of hands-on professional competence.
4 roles · 0 guidelines · 1 courses · 1 providers
Structured PAP process navigation
The course teaches the overall PAP workflow from screening through follow-up. Learners are expected to understand and explain each phase of treatment in a structured way.
4 roles · 0 guidelines · 1 courses · 1 providers
KetamineSupervised experiential practice
A defining feature of the training is hands-on experiential practice in both non-substance and substance-based modalities under supervision. Learners practice patient and therapist roles, facilitating and undergoing sessions in a structured learning context.
4 roles · 0 guidelines · 1 courses · 1 providers
PsilocybinSupervised practicum and feedback integration
Students complete 50 supervised practicum hours and receive expert feedback while working with real clients. This is intended to translate theory into competent applied practice.
4 roles · 0 guidelines · 1 courses · 1 providers
Supporting diverse spiritual and community contexts
The program states it prepares facilitators to address the needs of clients, patients, or community members from diverse faith traditions and communities of origin. Learners are expected to adapt facilitation to varied settings and worldviews.
3 roles · 0 guidelines · 1 courses · 1 providers
Sustainable practice development and prescriber coordination
The course teaches practical steps to launch and sustain a KAP practice, including forging relationships with prescribers and identifying suitable practicum sites. This is framed as part of professional development and business planning.
4 roles · 0 guidelines · 1 courses · 1 providers
KetamineTherapeutic technique enhancement
Vital says learners will expand their skills and enhance therapeutic techniques. This suggests training in improving how they support clients in psychedelic-related therapeutic work.
3 roles · 0 guidelines · 1 courses · 1 providers
Tracking nervous systems and consent dynamics
The Colorado practicum site explicitly teaches relational competence, including tracking nervous systems, power, and consent dynamics moment by moment. This is presented as a core facilitation capability.
4 roles · 0 guidelines · 1 courses · 1 providers
PsilocybinUse of complementary support methods
Students explore how psychedelics can be integrated with supportive methods such as breathwork, meditation, cold therapy, and neurofeedback. The course emphasizes a holistic toolkit rather than a single-method approach.
3 roles · 0 guidelines · 1 courses · 1 providers
Use structured preparedness frameworks
The course is positioned as a preparedness-oriented training with self-directed preparation plus live facilitated learning. Learners are expected to internalize a framework for managing challenging or crisis moments with confidence and care.
5 roles · 0 guidelines · 1 courses · 1 providers
Bilingual and bicultural engagement
The page explicitly signals the value of bilingual and bicultural heritage as a foundation for practice. This points to competence in communicating and relating across language and cultural context.
3 roles · 0 guidelines · 0 courses · 1 providers
Hybrid in-person and virtual session support
The course teaches students to guide both in-person and online sessions, including the technical skills needed for virtual facilitation. It explicitly notes that online training includes learning tech skills to become a confident virtual guide.
3 roles · 0 guidelines · 0 courses · 1 providers
PsilocybinKetamineDMT / Ayahuasca+1 moreTherapeutic support in patient care settings
The page highlights extensive patient care experience and a background in holistic counseling psychology, suggesting practical competence in supporting participants in clinical or care environments. This is more general care-setting competence than protocol-specific technique.
4 roles · 0 guidelines · 0 courses · 1 providers
General psychedelic-assisted practice skills
Catch-all cluster covering 189 general competencies for psychedelic-assisted clinical practice that did not group into a more specific category — including miscellaneous facilitation, monitoring, ethics, safety, regulatory awareness, group support, and program-specific skills not captured by dedicated clusters elsewhere.
8 roles · 45 guidelines · 27 courses · 18 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 more
Other care stages
Follow the competency map across the care pathway.